MDAI

A selective serotonin releasing agent which is rarely used without a stimulant to obtain desirable effects. Previously believed not to be neuruotoxic, however MDAI has been implicated in several lethal and non-lethal intoxications, and as such may pose more of a risk to health than previously believed.

Classification

Chemical: Aminoindane
Psychoactive: Entactogen
Psychoactive: Psychedelic
Psychoactive: Stimulant
Tag: Empathogen
Tag: Habit-Forming
Tag: Research-Chemical

Effects

Increased Heart Rate
Stimulation
Insomnia
Nausea
Decreased Appetite
Increased Energyalertness
Talkativeness
Alertness Enhancement
Euphoria
Time Distortion
Confusion
Anxiety
Light Sensitivity
Tracers
Color Enhancement
Open Eye Visuals
Dehydration
Pattern Recognition Enhancement

Routes of Administration

Oral

Dosage

Common: 100-150 mg
Heavy: 150-300 mg
Light: 40-100 mg
Threshold: 20-40 mg
Strong: 175-300 mg

Duration

Onset: 0.3-0.7 h
Comeup: 0.5-1 h
Peak: 2-2.5 h
Offset: 1-2 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu